Debate on "dual pathway inhibition": Antiplatelet therapy in patients with peripheral atherosclerotic disease: old but gold?

被引:1
|
作者
Spaccarotella, Carmen [1 ]
Simonetti, Fiorenzo [1 ]
Piccolo, Raffaele [1 ]
Esposito, Giovanni [1 ]
机构
[1] Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Via Pansini 5, I-80131 Naples, Italy
关键词
ANKLE BRACHIAL INDEX; CARDIOVASCULAR EVENTS; ARTERY-DISEASE; RISK; PREVENTION; ASPIRIN; CLOPIDOGREL; MORTALITY;
D O I
10.1714/4035.40103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:24S / 27S
页数:4
相关论文
共 50 条
  • [1] Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease
    Galli, Mattia
    Franchi, Francesco
    Rollini, Fabiana
    Been, Latonya
    Abou Jaoude, Patrick
    Rivas, Andrea
    Zhou, Xuan
    Jia, Sida
    Maaliki, Naji
    Lee, Chang Hoon
    Pineda, Andres M.
    Suryadevara, Siva
    Soffer, Daniel
    Zenni, Martin M.
    Geisler, Tobias
    Jennings, Lisa K.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (08) : 1341 - 1351
  • [2] Antiplatelet therapy of patients with peripheral arterial disease
    Poredos, P.
    MULTIDISCIPLINARY APPROACH TO CARDIOVASCULAR DISEASES, 2016, : 12 - 16
  • [3] Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
    Magnani, Giulia
    Denegri, Andrea
    Gurgoglione, Filippo Luca
    Barocelli, Federico
    Indrigo, Elia
    Catellani, Davide
    Signoretta, Gianluca
    Bettella, Alberto
    Tuttolomondo, Domenico
    Solinas, Emilia
    Nicolini, Francesco
    Niccoli, Giampaolo
    Ardissino, Diego
    Surdacki, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (16)
  • [4] Association of antiplatelet therapy with clinical outcomes in patients with peripheral artery disease
    Al-Sadawi, Mohammed
    Tao, Michael
    Dhaliwal, Simrat
    Masson, Ravi
    Bhagat, Aditi A.
    Parikh, Puja B.
    Lawson, William E.
    Reilly, John P.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 62 : 66 - 72
  • [5] Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications
    Galli, Mattia
    Franchi, Francesco
    Rollini, Fabiana
    Ortega-Paz, Luis
    D'Amario, Domenico
    De Caterina, Raffaele
    Mehran, Roxana
    Gibson, C. Michael
    Angiolillo, Dominick J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (01) : 27 - 38
  • [6] Dual Antiplatelet Therapy or Dual Pathway Inhibition
    Goto, Shinya
    Goto, Shinichi
    THROMBOSIS AND HAEMOSTASIS, 2023,
  • [7] Comparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy after Endovascular Therapy in Patients with Lower Extremity Artery Disease
    Yamada, Takehiro
    Tokuda, Takahiro
    Yoshioka, Naoki
    Koyama, Akio
    Nishikawa, Ryusuke
    Shimamura, Kiyotaka
    Aoyama, Takuma
    ANNALS OF VASCULAR DISEASES, 2024, 17 (04) : 396 - 404
  • [8] Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease
    Armstrong, Ehrin J.
    Anderson, David R.
    Yeo, Khung-Keong
    Singh, Gagan D.
    Bang, Heejung
    Amsterdam, Ezra A.
    Freischlag, Julie A.
    Laird, John R.
    JOURNAL OF VASCULAR SURGERY, 2015, 62 (01) : 156 - 165
  • [9] Optimizing platelet inhibition in peripheral artery disease: A comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography
    Lee, Ivy
    Suarez, Sasha
    Hall, Ryan
    Majumdar, Monica
    Bellomo, Tiffany
    Jessula, Samuel
    Nuzzolo, Kathryn
    Jefferson, Douglas M.
    Zacharias, Nikolaos
    Dua, Anahita
    VASCULAR, 2025, 33 (01) : 3 - 18
  • [10] Dual Antiplatelet Therapy for Patients with Cardiovascular Disease
    McLaughlin, Erin
    Leggett, Shauna
    Kelsberg, Gary
    Safranek, Sarah
    AMERICAN FAMILY PHYSICIAN, 2019, 100 (08) : 463 - 464